
Advancing Clinical Care @ISOQOL conference
On the 20th of October 2022, PROMinsight’s very own CTO and co-founder, Assoc. Prof Eva Fenwick took the stage at the International Society for Quality of Life Research (ISOQOL) conference in Prague, Czech Republic. Assoc. Prof Eva Fenwick described the feasibility of implementing vision-specific quality of life computerized adaptive tests (CATs) in Singaporean cataract outpatient clinics.
Showcasing PROMinsight’s CAT implementation work @IACAT
Attending as part of an Invited Symposium “Applications of CAT across multiple fields using the Concerto platform”, Prof Ecosse Lamoureux recently showcased PROMinsight’s CAT implementation efforts in tertiary eye care at the International Association for Computerized Adaptive Testing (IACAT) conference in Frankfurt, Germany
Working with Visibility Scotland to evaluate support services in children with vision impairment
Using the IVI_C to to evaluate the effectiveness of Disability Scotland’s support services in children.
AI-driven quality of life assessments: supporting value-based healthcare in glaucoma @Mass. Eye and Ear Hospital
In value-based healthcare systems, understanding and improving patient health outcomes is central.
Measuring the patient-centred effectiveness of PHACO-MIGS using GlauCAT
PHACO-MIGS can significantly improve a range of quality of life outcomes in patients with early stage glaucoma.
Assessing cost-effectiveness of glaucoma treatments with Glau-U
Glau-U utilities decreased as glaucoma severity increased, demonstrating reductions of up to 41% in quality-adjusted life-years compared with glaucoma suspects.